|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | A61K 47/48 | (2006.01) |
| (11) | Number of the document | 2134371 |
| (13) | Kind of document | T |
| (96) | European patent application number | 08742082.4 |
| Date of filing the European patent application | 2008-03-12 | |
| (97) | Date of publication of the European application | 2009-12-23 |
| (45) | Date of publication and mention of the grant of the patent | 2015-01-14 |
| (46) | Date of publication of the claims translation | 2015-06-25 |
| (86) | Number | PCT/US2008/003353 |
| Date | 2008-03-12 |
| (87) | Number | WO 2008/112288 |
| Date | 2008-09-18 |
| (30) | Number | Date | Country code |
| 906387 P | 2007-03-12 | US |
| (72) |
RIGGS-SAUTHIER, Jennifer, US
DENG, Bo-liang, US
RILEY, Timothy, Andrew, US
|
| (73) |
Nektar Therapeutics,
455 Mission Bay Boulevard South, Suite 100, San Francisco, CA 94158,
US
|
| (74) |
Liudmila GERASIMOVIČ,
IĮ "Liudmila Gerasimovič, Patentinis patikėtinis", Vingrių g. 13-42, LT-01141 Vilnius,
LT
|
| (54) | Oligomero-opioido agonisto konjugatai |
| OLIGOMER-OPIOID AGONIST CONJUGATES |
| Payment date | Validity (years) | Amount | |
| 2020-03-02 | 13 | 289.00 EUR |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2021-03-12 |